Document
IPR2023-01103, No. 1055 Exhibit - Stelara, European Medicines Agency Website (P.T.A.B. Jun. 21, 2023)
Cite Document
IPR2023-01103, No. 1055 Exhibit - Stelara, European Medicines Agency Website (P.T.A.B. Jun. 21, 2023)
+ More Snippets
Document
IPR2023-01103, No. 1034 Exhibit - Kolios et al 2018 (P.T.A.B. Jun. 21, 2023)
Cite Document
IPR2023-01103, No. 1034 Exhibit - Kolios et al 2018 (P.T.A.B. Jun. 21, 2023)
+ More Snippets
Document
IPR2023-01103, No. 1051 Exhibit - Higgins, et al 2005 (P.T.A.B. Jun. 21, 2023)
Cite Document
IPR2023-01103, No. 1051 Exhibit - Higgins, et al 2005 (P.T.A.B. Jun. 21, 2023)
+ More Snippets
Document
IPR2023-01103, No. 1021 Exhibit - Application for Extension of Patent Term for US Patent No 7,166,285 (P.T.A.B. Jun. 21, 2023)
Cite Document
IPR2023-01103, No. 1021 Exhibit - Application for Extension of Patent Term for US Patent No 7,166,285 (P.T.A.B. Jun. 21, 2023)
+ More Snippets
Document
IPR2023-01103, No. 1026 Exhibit - Feagan et al Nov 17, 2016 (P.T.A.B. Jun. 21, 2023)
Cite Document
IPR2023-01103, No. 1026 Exhibit - Feagan et al Nov 17, 2016 (P.T.A.B. Jun. 21, 2023)
+ More Snippets
Document
IPR2023-01103, No. 1062 Exhibit - Webarchive of “Study of Vedolizumab MLN0002 in Patients (P.T.A.B. Jun. 21, 2023)
Cite Document
IPR2023-01103, No. 1062 Exhibit - Webarchive of “Study of Vedolizumab MLN0002 in Patients (P.T.A.B. Jun. 21, 2023)
+ More Snippets
Document
IPR2023-01103, No. 1070 Exhibit - Ustekinumab Stelara, Canadian Agency for Drugs and Technologies in Health (P.T.A.B. Jun. 21, 2023)
Cite Document
IPR2023-01103, No. 1070 Exhibit - Ustekinumab Stelara, Canadian Agency for Drugs and Technologies in Health (P.T.A.B. Jun. 21, 2023)
+ More Snippets
Document
IPR2023-01103, No. 1044 Exhibit - Glossary of Common Site Terms, ClinicalTrialsgov Oct 2021 (P.T.A.B. Jun. 21, 2023)
Cite Document
IPR2023-01103, No. 1044 Exhibit - Glossary of Common Site Terms, ClinicalTrialsgov Oct 2021 (P.T.A.B. Jun. 21, 2023)
+ More Snippets
Document
IPR2023-01103, No. 1012 Exhibit - Uhlig et al Aug 2006 (P.T.A.B. Jun. 21, 2023)
Cite Document
IPR2023-01103, No. 1012 Exhibit - Uhlig et al Aug 2006 (P.T.A.B. Jun. 21, 2023)
+ More Snippets
Document
IPR2023-01103, No. 1017 Exhibit - Sandborn et al 2008 (P.T.A.B. Jun. 21, 2023)
Cite Document
IPR2023-01103, No. 1017 Exhibit - Sandborn et al 2008 (P.T.A.B. Jun. 21, 2023)
+ More Snippets
Document
IPR2023-01103, No. 1011 Exhibit - Ahern et al Aug 2010 (P.T.A.B. Jun. 21, 2023)
Cite Document
IPR2023-01103, No. 1011 Exhibit - Ahern et al Aug 2010 (P.T.A.B. Jun. 21, 2023)
+ More Snippets
Document
IPR2023-01103, No. 1047 Exhibit - History of Changes for Study NCT02407236, ClinicalTrialsgov archive (P.T.A.B. Jun. 21, 2023)
Cite Document
IPR2023-01103, No. 1047 Exhibit - History of Changes for Study NCT02407236, ClinicalTrialsgov archive (P.T.A.B. Jun. 21, 2023)
+ More Snippets
Document
IPR2023-01103, No. 1019 Exhibit - US Patent No 7,166,285 (P.T.A.B. Jun. 21, 2023)
Cite Document
IPR2023-01103, No. 1019 Exhibit - US Patent No 7,166,285 (P.T.A.B. Jun. 21, 2023)
+ More Snippets
Document
IPR2023-01103, No. 1063 Exhibit - Sequence published with International Publication Number WO 2015119841 (P.T.A.B. Jun. 21, 2023)
Cite Document
IPR2023-01103, No. 1063 Exhibit - Sequence published with International Publication Number WO 2015119841 (P.T.A.B. Jun. 21, 2023)
+ More Snippets
Document
IPR2023-01103, No. 1033 Exhibit - Tarr et al 2014 (P.T.A.B. Jun. 21, 2023)
Cite Document
IPR2023-01103, No. 1033 Exhibit - Tarr et al 2014 (P.T.A.B. Jun. 21, 2023)
+ More Snippets